CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories' immunoassay testing equipment. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was incorporated in 1997 and is based in Mississauga, Canada.
Frequently asked questions
What sector does CardioGenics Holdings Inc (CGNH) operate in?
CardioGenics Holdings Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is CardioGenics Holdings Inc (CGNH) current stock price?
As of the latest data, CardioGenics Holdings Inc stock price is $0.00, with a previous close of $0.00.
What is CardioGenics Holdings Inc (CGNH) current market capitalization?
CardioGenics Holdings Inc market cap is approximately 9.61 thousand.
Does CardioGenics Holdings Inc (CGNH) pay dividends?
No. CardioGenics Holdings Inc does not pay a dividend.
What is CardioGenics Holdings Inc (CGNH) beta (volatility) score?
CardioGenics Holdings Inc has a beta of 68.391, indicating very high volatility compared to the market.